Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $56.28 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $24.98 | 1 | $0 (2024) |
| PFIZER INC. | $19.32 | 1 | $0 (2024) |
| Nabriva Therapeutics, plc | $11.98 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.30 | 2 | AstraZeneca Pharmaceuticals LP ($24.98) |
| 2022 | $11.98 | 1 | Nabriva Therapeutics, plc ($11.98) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/23/2022 | Nabriva Therapeutics, plc | Sivextro (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Oxazolidinone antibiotics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 52 | 52 | $17,407 | $5,538 |
| 2022 | 5 | 117 | 121 | $17,782 | $5,190 |
| 2021 | 9 | 204 | 216 | $27,915 | $11,307 |
| 2020 | 4 | 132 | 140 | $21,520 | $8,717 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $17,407 | $5,538 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $8,862 | $2,124 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 41 | $5,971 | $2,044 | 34.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 14 | 15 | $1,875 | $528.89 | 28.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 11 | 11 | $990.00 | $453.11 | 45.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 12 | $84.00 | $41.28 | 49.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 55 | 55 | $9,869 | $3,580 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 45 | $5,232 | $2,320 | 44.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,883 | $2,096 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $2,847 | $1,611 | 56.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 21 | 22 | $2,750 | $777.26 | 28.3% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 11 | 11 | $990.00 | $455.18 | 46.0% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 12 | 21 | $624.00 | $347.55 | 55.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 12 | $456.00 | $88.62 | 19.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 14 | $264.00 | $31.50 | 11.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 63 | $9,765 | $3,990 | 40.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 30 | 30 | $7,170 | $2,894 | 40.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $4,185 | $1,790 | 42.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 18 | 20 | $400.00 | $42.30 | 10.6% |
About Elizabeth Matre, DNP, FNP-BC
Elizabeth Matre, DNP, FNP-BC is a Family healthcare provider based in Upper Arlington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1366899486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Matre, DNP, FNP-BC has received a total of $56.28 in payments from pharmaceutical and medical device companies, with $44.30 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($56.28).
As a Medicare-enrolled provider, Matre has provided services to 505 Medicare beneficiaries, totaling 529 services with total Medicare billing of $30,753. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Upper Arlington, OH
- Active Since 05/18/2016
- Last Updated 06/01/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1366899486
Products in Payments
- AIRSUPRA (Drug) $24.98
- PAXLOVID (Drug) $19.32
- Sivextro (Drug) $11.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Upper Arlington
Brooke Laturell
Family — Payments: $873.90
Peter Dipiazza, Dnp, Bc-Fnp, DNP, BC-FNP
Family — Payments: $644.43
Caroline Baker, Np, NP
Family — Payments: $434.26
Laura Seiler, Np, NP
Family — Payments: $352.74
Taylor Hale, Np, NP
Family — Payments: $260.96
Cassandra Bernard
Family — Payments: $234.39